Many people incorrectly assume that bowel cancer has a predominately genetic history. The reality is that more than 75% of people who develop bowel cancer do not have a family history of the disease. Both women and men are at risk of developing the disease, which affects 1 in 10 men and 1 in 15 women in Australia before the age of 85.This is one of the highest rates of bowel cancer in the world; however with early detection around 90% of cases can be treated effectively. We know that early diagnosis improves treatment outcomes.
GMHBA are proud to provide our Bowel Cancer Risk Identification Program to enable our members to access the highly accurate ColoVantage® Home faecal immunochemical test (FIT) kit and become part of reminder system for ongoing regular screening. Of the 7,000 members who have purchased the test, 400 have returned a positive result – this may have saved them from major surgery or even saved their lives.
The ColoVantage® Home kit is a quick, easy, non-invasive and painless test that is undertaken in the privacy of your own home. It simply requires taking the brush supplied and applying a sample of stool onto the test indicators and posting them in the reply paid envelope for analysis.
Of the 7000 GMHBA members who have already purchased the FIT test, 400 returned a positive result. This may have saved them from major surgery or even saved their lives.
Any GMHBA member can take part in the program by contacting GMHBA directly. The cost of the program can be paid for by cash, credit card or cheque, or by using extras cover if eligible (limited to one kit per person each 2 years).
To order your kit you can:
Members with eligible extras cover can order the kits online.
For more information on bowel health, visit bowelcanceraustralia.org or call (02) 9923 8269